Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.40 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL670608 | 1.00 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| SCHEMBL670046 | 1.00 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| Hydrochloric Acid SCHEMBL670045 | 0.99 | SMN1; SMN2 (0.44) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| Hydrochloric Acid SCHEMBL16742846 | 0.99 | SMN1; SMN2 (0.44) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| SCHEMBL15109995 | 0.82 | BCL2 (0.55) | SMN1; SMN2 | |
| SCHEMBL2558812 | 0.81 | SMN1; SMN2 (0.45) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL2554080 | 0.81 | SMN1; SMN2 (0.45) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL354856 | 0.79 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| SCHEMBL117975 | 0.79 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 | |
| SCHEMBL18897543 | 0.79 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2CALM1CAMKK2AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013105109-A1 | PROCESS FOR THE PREPARATION OF TAPENTADOL | INDOCO REMEDIES LIMITED (IN) | 2013-07-18 | — | — | WO | claimed |
| EP-3285745-A1 | TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION | Grünenthal GmbH (DE) | 2018-02-28 | — | — | EP | disclosed |
| WO-2016170097-A1 | TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION | Grünenthal GmbH (DE) | 2016-10-27 | — | — | WO | disclosed |
| EP-3082781-A1 | TAMPER RESISTANT DOSAGE FORM WITH BIMODAL RELEASE PROFILE MANUFACTURED BY CO-EXTRUSION | Grünenthal GmbH (DE) | 2016-10-26 | — | — | EP | disclosed |
| EP-3063125-A1 | NOVEL INTERMEDIATE OF TAPENTADOL | Sun Pharma Advanced Research Company (IN) | 2016-09-07 | — | — | EP | disclosed |
| EP-3019157-A1 | TAMPER-RESISTANT DOSAGE FORM CONTAINING ETHYLENE-VINYL ACETATE POLYMER | Grünenthal GmbH (DE) | 2016-05-18 | — | — | EP | disclosed |
| EP-3003283-A1 | TAMPER RESISTANT DOSAGE FORM WITH BIMODAL RELEASE PROFILE | Grünenthal GmbH (DE) | 2016-04-13 | — | — | EP | disclosed |
| EP-3003279-A1 | TAMPER-RESISTANT DOSAGE FORM CONTAINING ONE OR MORE PARTICLES | Grünenthal GmbH (DE) | 2016-04-13 | — | — | EP | disclosed |
| WO-2015091352-A1 | TAMPER RESISTANT DOSAGE FORM WITH BIMODAL RELEASE PROFILE MANUFACTURED BY CO-EXTRUSION | Grünenthal GmbH (DE) | 2015-06-25 | — | — | WO | disclosed |
| WO-2015075744-A1 | NOVEL INTERMEDIATE OF TAPENTADOL | SUN PHARMA ADVANCED RESEARCH COMPANY (IN) | 2015-05-28 | — | — | WO | disclosed |
| WO-2014191396-A1 | TAMPER RESISTANT DOSAGE FORM WITH BIMODAL RELEASE PROFILE | Grünenthal GmbH (DE) | 2014-12-04 | — | — | WO | disclosed |
| WO-2014191397-A1 | TAMPER-RESISTANT DOSAGE FORM CONTAINING ONE OR MORE PARTICLES | Grünenthal GmbH (DE) | 2014-12-04 | — | — | WO | disclosed |
| EP-2787978-A1 | PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY (EPSILON- CAPROLACTONE) AND POLYETHYLENE OXIDE | Purdue Pharma LP (US) | 2014-10-15 | — | — | EP | disclosed |
| WO-2013111161-A2 | PROCESS FOR THE PREPARATION OF 3-ARYL-2-METHYL-PROPANAMINE DERIVATIVES AND POLYMORPHS THEREOF | MSN LABORATORIES LIMITED (IN) | 2013-08-01 | — | — | WO | disclosed |
| WO-2013105109-A1 | PROCESS FOR THE PREPARATION OF TAPENTADOL | INDOCO REMEDIES LIMITED (IN) | 2013-07-18 | — | — | WO | disclosed |
| EP-2606030-A1 | PROCESS FOR THE PREPARATION OF TAPENTADOL | Indoco Remedies Limited (IN) | 2013-06-26 | — | — | EP | disclosed |
| WO-2013084059-A1 | PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY (EPSILON- CAPROLACTONE) AND POLYETHYLENE OXIDE | PURDUE PHARMA L.P. (US) | 2013-06-13 | — | — | WO | disclosed |
| EP-2519100-A1 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF TAPENTADOL AND RELATED COMPOUNDS | Mapi Pharma Limited (IL) | 2012-11-07 | — | — | EP | disclosed |
| WO-2012023147-A1 | PROCESS FOR THE PREPARATION OF TAPENTADOL | INDOCO REMEDIES LIMITED (IN) | 2012-02-23 | — | — | WO | disclosed |
| WO-2011080736-A1 | INTERMEDIATE COMPOUNDS AND PROCESSES FOR THE PREPARATION OF TAPENTADOL AND RELATED COMPOUNDS | MAPI PHARMA HK LIMITED (CN) | 2011-07-07 | — | — | WO | disclosed |